Anti-PD-1 Therapy plus Chemotherapy and/or Bevacizumab as Second Line or later Treatment for Patients with Advanced Non-Small Cell Lung Cancer.
Zhang F, Huang D, Li T, Zhang S, Wang J, Zhang Y, Wang G, Zhao Z, Ma J, Wang L, Sun D, Cui P, Cai S, Jiao S, Zhao L, Hu Y.
Zhang F, et al. Among authors: wang g, wang l, wang j.
J Cancer. 2020 Jan 1;11(3):741-749. doi: 10.7150/jca.37966. eCollection 2020.
J Cancer. 2020.
PMID: 31942197
Free PMC article.